TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 28258090

Group type: EXPERIMENTAL
Intervention: Vildagliptin (50mg)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo (for Vildagliptin)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Metformin (850mg)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo (for Metformin)
Number of subjects: 25
Study: 25359384

Group type: EXPERIMENTAL
Intervention: RVmIVS pacing
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: RVOT pacing
Number of subjects: 22

Group type: COMPARATOR
Intervention: Cardiac resynchronization therapy (CRT)
Number of subjects: 22
Study: 23944945

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate nasal drops (FPND)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Functional endoscopic sinus surgery (FESS)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Combined therapy of FPND and FESS
Number of subjects: 60
Study: 21333458

Group type: EXPERIMENTAL
Intervention: COMBOHP (combination high protein diet; 0.92% creatine monohydrate and 2.75% dextrose with minimum 16% crude protein)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: COMBO (combination diet; 0.92% creatine monohydrate and 2.75% dextrose)
Number of subjects: 48

Group type: COMPARATOR
Intervention: CON (control; basal diet consisting of a ground corn‐soybean base)
Number of subjects: 48
Study: 19803567

Group type: EXPERIMENTAL
Intervention: Norwegian Universal Preventive Program for Social Anxiety (NUPP‐SA)
Number of subjects: 1748

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 1748
Study: 16892780

Group type: EXPERIMENTAL
Intervention: Asthma education (AE) program after an ED visit
Number of subjects: 239

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 239
Study: 15275840

Group type: EXPERIMENTAL
Intervention: Squatting during descent
Number of subjects: 23

Group type: COMPARATOR
Intervention: Inhibited squatting
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Release angle of 5 degrees
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Release angle of 12 degrees
Number of subjects: 23
Study: 11641592

Group type: EXPERIMENTAL
Intervention: 10 mg of amphetamine combined with physiotherapy for 10 sessions over 5 weeks
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 39
Study: 9128822

Group type: EXPERIMENTAL
Intervention: Oxitropium bromide 375 micrograms
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Oxitropium bromide 750 micrograms
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Oxitropium bromide 1500 micrograms
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Fenoterol 400 micrograms
Number of subjects: 20
Study: 7967408

Group type: EXPERIMENTAL
Intervention: Small central capsulotomy without dilating the pupil
Number of subjects: 20

Group type: COMPARATOR
Intervention: Large capsulotomy through dilated pupils
Number of subjects: 20
Study: 3189262

Group type: EXPERIMENTAL
Intervention: Intragastric provocation under endoscopic control (IPEC)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Skin and RAST tests
Number of subjects: 30
Study: 31287257

Group type: EXPERIMENTAL
Intervention: Combined spinal-epidural anesthesia (CSEA)
Number of subjects: 95

Group type: COMPARATOR
Intervention: General anesthesia (GA)
Number of subjects: 95
Study: 28847457

Group type: EXPERIMENTAL
Intervention: Long-acting naltrexone
Number of subjects: 306
Study: 25192689

Group type: EXPERIMENTAL
Intervention: Hamstring-tendon graft
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Patellar-tendon graft
Number of subjects: 40

Group type: COMPARATOR
Intervention: Both graft types
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Patellar-tendon graft with rehabilitation
Number of subjects: 40
Study: 22801937

Group type: EXPERIMENTAL
Intervention: Vaginal estrogen therapy (estradiol, E(2)) with vaginal mesh prolapse surgery (VM)
Number of subjects: 448

Group type: EXPERIMENTAL
Intervention: Vaginal estrogen therapy (estradiol, E(2)) with minimally invasive sacral colpopexy (MISC)
Number of subjects: 448

Group type: COMPARATOR
Intervention: Vaginal mesh prolapse surgery (VM) without vaginal estrogen therapy
Number of subjects: 448

Group type: COMPARATOR
Intervention: Minimally invasive sacral colpopexy (MISC) without vaginal estrogen therapy
Number of subjects: 448
Study: 21365652

Group type: EXPERIMENTAL
Intervention: supportive‐expressive psychotherapy
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: medication
Number of subjects: 156

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 156
Study: 18642998

Group type: EXPERIMENTAL
Intervention: print‐based feedback
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: telephone‐based feedback
Number of subjects: 239

Group type: COMPARATOR
Intervention: contact control
Number of subjects: 239
Study: 17699370

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 15030266

Group type: EXPERIMENTAL
Intervention: AGI‐1067
Number of subjects: 0
Study: 10937510

Group type: EXPERIMENTAL
Intervention: Insulin glargine
Number of subjects: 426

Group type: COMPARATOR
Intervention: NPH insulin
Number of subjects: 426
Study: 8606694

Group type: EXPERIMENTAL
Intervention: Lithium carbonate (600 mg b.i.d. x 6 days)
Number of subjects: 12
Study: 1413136

Group type: EXPERIMENTAL
Intervention: Fish oil (6 g daily for four weeks)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Safflower oil (equivalent amounts to fish oil)
Number of subjects: 9
Study: 31204333

Group type: EXPERIMENTAL
Intervention: Capsule lycopene
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Capsule lycopene and injection dexamethasone
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Injection dexamethasone and hyaluronidase
Number of subjects: 60
Study: 29734362

Group type: EXPERIMENTAL
Intervention: Maxillary appliance
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Intermittent use of appliances
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Maxillary appliance in an intermittent regimen
Number of subjects: 15
Study: 26079108

Group type: EXPERIMENTAL
Intervention: Single vision lenses (SVLs)
Number of subjects: 469

Group type: COMPARATOR
Intervention: Progressive addition lenses (PALs)
Number of subjects: 469

Group type: COMPARATOR
Intervention: Control group (non-progressing myopia)
Number of subjects: 469
Study: 24483757

Group type: EXPERIMENTAL
Intervention: nifedipine 20 mg Q 8‐hourly
Number of subjects: 110

Group type: COMPARATOR
Intervention: progesterone 400 mg daily
Number of subjects: 110
Study: 22019244

Group type: EXPERIMENTAL
Intervention: Multiple kilovoltage (kV) and megavoltage (MV) imaging of implanted gold markers during treatment
Number of subjects: 108
Study: 20873071

Group type: EXPERIMENTAL
Intervention: Knowledge sharing practices with empowerment strategies (KSPES) program on antenatal education and postnatal support strategies
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard knowledge of breastfeeding techniques (control group)
Number of subjects: 0
Study: 18399897

Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Subcutaneous immunotherapy (SCIT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both SLIT and SCIT
Number of subjects: 0
Study: 16098253

Group type: EXPERIMENTAL
Intervention: LDCI 5‐FU 300 mg/m(2) per day for 28 days every 5 weeks
Number of subjects: 730

Group type: COMPARATOR
Intervention: HDI 5‐FU 2,600 mg/m(2) for 24 hours each week
Number of subjects: 730
Study: 12439085

Group type: EXPERIMENTAL
Intervention: Stationary cycling (BK)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Weightlifting (WTS)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Nonexercise control day (Con)
Number of subjects: 10
Study: 10511326

Group type: EXPERIMENTAL
Intervention: Fruit, Juice, and Vegetable Food Frequency Questionnaire (FFQ)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Fruit, Juice, and Vegetable Food Recognition Form (FRF)
Number of subjects: 96

Group type: COMPARATOR
Intervention: 24-hour dietary recalls (24hdr)
Number of subjects: 96
Study: 7742151

Group type: EXPERIMENTAL
Intervention: Simvastatin (10-40 mg day-1 for three periods of 6 weeks)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Pravastatin (10-40 mg day-1 for three periods of 6 weeks)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Simvastatin
Number of subjects: 24

Group type: COMPARATOR
Intervention: Pravastatin
Number of subjects: 24
Study: 2036922

Group type: EXPERIMENTAL
Intervention: Metoclopramide administered intravenously every 8 hours until solid food diet tolerated
Number of subjects: 93

Group type: COMPARATOR
Intervention: No metoclopramide (Control Group)
Number of subjects: 93
Study: 7091898

Group type: COMPARATOR
Intervention: Spontaneous cough while at rest (control)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Postural drainage
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Postural drainage plus mechanical percussion
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Combined maneuvers (postural drainage, deep breathing with vibrations, and percussion) administered by a physiotherapist
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Directed vigorous cough
Number of subjects: 6
Study: 30957867

Group type: EXPERIMENTAL
Intervention: Web-based intervention (WBI)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 118
Study: 31091129

Group type: EXPERIMENTAL
Intervention: Anatomic transtibial pull‐out root repair
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Anatomic transtibial pull‐out root repair with centralization
Number of subjects: 10

Group type: COMPARATOR
Intervention: Nonanatomic transtibial pull‐out repair
Number of subjects: 10

Group type: COMPARATOR
Intervention: Nonanatomic transtibial pull‐out repair with centralization
Number of subjects: 10

Group type: COMPARATOR
Intervention: Intact state
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Loaded knees at 90° flexion
Number of subjects: 10

Group type: COMPARATOR
Intervention: Unloaded knees at full extension
Number of subjects: 10
Study: 29017481

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral group therapy (STEpS)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 76
Study: 25910804

Group type: EXPERIMENTAL
Intervention: SR-nitrite (80 mg, twice daily by mouth for 21 days)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 23815634

Group type: COMPARATOR
Intervention: Unilateral stimulation (anodal-tDCS over non-dominant M1)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Bilateral stimulation (anodal-tDCS over non-dominant M1 and cathodal-tDCS over dominant M1)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Sham stimulation
Number of subjects: 11
Study: 21543158

Group type: EXPERIMENTAL
Intervention: Moderate intensity aerobic exercise
Number of subjects: 60

Group type: COMPARATOR
Intervention: Contact control
Number of subjects: 60
Study: 19523212

Group type: EXPERIMENTAL
Intervention: multiple traffic light label
Number of subjects: 420

Group type: COMPARATOR
Intervention: no label
Number of subjects: 420
Study: 17970675

Group type: EXPERIMENTAL
Intervention: Non-surgical periodontal therapy during gestation
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (periodontal treatment after delivery)
Number of subjects: 200
Study: 15496697

Group type: EXPERIMENTAL
Intervention: Midazolam 2-4 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Etomidate 0.2-0.3 mg/kg
Number of subjects: 0
Study: 11563998

Group type: EXPERIMENTAL
Intervention: Pantoprazole (20 mg)
Number of subjects: 328

Group type: COMPARATOR
Intervention: Omeprazole (20 mg)
Number of subjects: 328
Study: 9729670

Group type: EXPERIMENTAL
Intervention: Salt fluoridation (350 ppm F-/kg)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Non-salt fluoridation (Control)
Number of subjects: 108
Study: 8065835

Group type: EXPERIMENTAL
Intervention: High-dose surfactant (200 mg/kg, max 600 mg/kg)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Low-dose surfactant (100 mg/kg, max 300 mg/kg)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Healthy comparison group (8 infants)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Both treatment schedules (high-dose and low-dose)
Number of subjects: 25
Study: 2848652

Group type: EXPERIMENTAL
Intervention: Acetate (15 mmol every 15 min)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Chloride (as control)
Number of subjects: 5
Study: 29278019

Group type: EXPERIMENTAL
Intervention: ReaDySpeech with usual care (n=26)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Usual care only (n=14)
Number of subjects: 40
Study: 27109827

Group type: EXPERIMENTAL
Intervention: Abiraterone acetate (Zytiga)
Number of subjects: 119
Study: 25703887

Group type: EXPERIMENTAL
Intervention: Cangrelor
Number of subjects: 2059
Study: 23972693

Group type: EXPERIMENTAL
Intervention: Teacher-delivered, brief, personality-targeted interventions (two 90-minute, CBT-based group interventions)
Number of subjects: 1024

Group type: EXPERIMENTAL
Intervention: Teacher-delivered, brief, personality-targeted interventions
Number of subjects: 1024
Study: 20587823

Group type: EXPERIMENTAL
Intervention: Implementation intention intervention
Number of subjects: 77

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 77
Study: 18696157

Group type: EXPERIMENTAL
Intervention: Scintigraphic appearance time (SAT) >30 min
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Scintigraphic appearance time (SAT)
Number of subjects: 194
Study: 28049190

Group type: COMPARATOR
Intervention: <sup>131</sup>I treatment
Number of subjects: 217

Group type: COMPARATOR
Intervention: Methylprednisolone treatment in combination with <sup>131</sup>I treatment
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: RTX in combination with <sup>131</sup>I treatment
Number of subjects: 217
Study: 12777589

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (FP) 200 micro g/d (max 400 micro g/d if uncontrolled)
Number of subjects: 174

Group type: COMPARATOR
Intervention: Nedocromil sodium (NS) 8 mg/d (max 16 mg/d if uncontrolled)
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (FP)
Number of subjects: 174

Group type: COMPARATOR
Intervention: Nedocromil sodium (NS)
Number of subjects: 174
Study: 11127339

Group type: EXPERIMENTAL
Intervention: Rice powder salt solution and milk-rice mixture (RPSS-MR group, n = 17)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Glucose-based oral rehydration solution combined with milk-rice mixture (ORS-MR group, n = 17)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Glucose-based oral rehydration solution combined with formula milk (ORS-milk group, n = 14)
Number of subjects: 48
Study: 9127460

Group type: EXPERIMENTAL
Intervention: Competitive one‐step enzyme‐linked immunosorbent assay (ELISA) using MAbA7
Number of subjects: 114

Group type: COMPARATOR
Intervention: Hormone replacement therapy (HRT)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Bisphosphonate therapy
Number of subjects: 114
Study: 8420740

Group type: EXPERIMENTAL
Intervention: 20 mg omeprazole
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 3532756

Group type: EXPERIMENTAL
Intervention: Cholestyramine plus diet
Number of subjects: 3806

Group type: COMPARATOR
Intervention: Placebo plus diet
Number of subjects: 3806

Group type: EXPERIMENTAL
Intervention: Diuretic use
Number of subjects: 3806
Study: 29635304

Group type: EXPERIMENTAL
Intervention: Checklist referrals (n = 255)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Free-text referrals (n = 256)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: All letters combined (n = 511)
Number of subjects: 32
Study: 27336314

Group type: EXPERIMENTAL
Intervention: Preventive ceftriaxone
Number of subjects: 836

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 836
Study: 25255587

Group type: EXPERIMENTAL
Intervention: Pomegranate juice supplementation
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control (tap water)
Number of subjects: 28
Study: 22715155

Group type: EXPERIMENTAL
Intervention: Intralipid infusion
Number of subjects: 10

Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 10
Study: 21232203

Group type: EXPERIMENTAL
Intervention: Local anesthesia
Number of subjects: 297

Group type: COMPARATOR
Intervention: General and spinal anesthesia
Number of subjects: 297
Study: 18430217

Group type: EXPERIMENTAL
Intervention: Full-time Boston brace wear
Number of subjects: 100

Group type: COMPARATOR
Intervention: No bracing (Control)
Number of subjects: 100
Study: 15753264

Group type: EXPERIMENTAL
Intervention: Planet Health obesity prevention program
Number of subjects: 480

Group type: COMPARATOR
Intervention: Control schools
Number of subjects: 480
Study: 12835602

Group type: EXPERIMENTAL
Intervention: Condition-specific measures of quality of life preceding generic instruments
Number of subjects: 62

Group type: COMPARATOR
Intervention: Generic instruments preceding condition-specific measures of quality of life
Number of subjects: 62
Study: 11109042

Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy
Number of subjects: 180000
Study: 8872598

Group type: EXPERIMENTAL
Intervention: Older adults (71 y and older)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Middle-aged men (37-52 y)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Older men (79 y+)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Older women (79 y+)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Young controls (19-28 y)
Number of subjects: 38
Study: 1320550

Group type: EXPERIMENTAL
Intervention: Four-component model for body composition assessment
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Three-component model for body composition assessment
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Deuterium dilution method
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Densitometry method
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Hydration fraction of fat-free mass
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Density of fat-free mass
Number of subjects: 28
Study: 6372924

Group type: EXPERIMENTAL
Intervention: Apomorphine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 29462033

Group type: EXPERIMENTAL
Intervention: Intravenous low-dose epinephrine plus tranexamic acid
Number of subjects: 179

Group type: COMPARATOR
Intervention: Topical diluted epinephrine plus tranexamic acid
Number of subjects: 179

Group type: COMPARATOR
Intervention: Tranexamic acid alone
Number of subjects: 179
Study: 27282230

Group type: EXPERIMENTAL
Intervention: True Positive (TP) alerts
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: False Positive (FP) alerts
Number of subjects: 66

Group type: COMPARATOR
Intervention: TP and FP alerts mixed
Number of subjects: 66
Study: 24343823

Group type: EXPERIMENTAL
Intervention: Therapeutic hypothermia (TH) for 72 hours, maintaining rectal temperature at 33-34°C
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Therapeutic hypothermia (TH)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no hypothermia)
Number of subjects: 0
Study: 22252782

Group type: COMPARATOR
Intervention: Normal faces
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Paralyzed faces
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Smiling (Normal faces)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Smiling (Paralyzed faces)
Number of subjects: 40
Study: 19627552

Group type: EXPERIMENTAL
Intervention: Single-dose breast milk
Number of subjects: 142

Group type: COMPARATOR
Intervention: Single-dose sterile water
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Single-dose 12.5% sucrose
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Two doses breast milk
Number of subjects: 142

Group type: COMPARATOR
Intervention: Two doses sterile water
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Two doses 12.5% sucrose
Number of subjects: 142
Study: 18556852

Group type: EXPERIMENTAL
Intervention: Short message service (SMS) via mobile phone for prenatal support (2 messages per week from 28 weeks of gestation until giving birth)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Short message service (SMS) via mobile phone for prenatal support
Number of subjects: 68

Group type: COMPARATOR
Intervention: General antenatal care (control group)
Number of subjects: 68
Study: 16091266

Group type: EXPERIMENTAL
Intervention: Unconscious priming with repeated visual displays
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unconscious priming with new visual displays
Number of subjects: 0
Study: 11929799

Group type: EXPERIMENTAL
Intervention: Oral valacyclovir (2 g) 4 times daily until week 18 after transplantation
Number of subjects: 727

Group type: COMPARATOR
Intervention: Oral acyclovir (800 mg) 4 times daily until week 18 after transplantation
Number of subjects: 727

Group type: EXPERIMENTAL
Intervention: Valacyclovir
Number of subjects: 727

Group type: COMPARATOR
Intervention: Acyclovir
Number of subjects: 727

Group type: EXPERIMENTAL
Intervention: Valacyclovir and Acyclovir
Number of subjects: 727
Study: 9448771

Group type: EXPERIMENTAL
Intervention: Olfactory stimuli (pyridine, menthone, amyl acetate)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Normal subjects (control group)
Number of subjects: 8
Study: 8546282

Group type: EXPERIMENTAL
Intervention: Intrathecal pethidine hydrochloride 0.50 mg.kg‐1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intrathecal pethidine hydrochloride 0.75 mg.kg‐1
Number of subjects: 0

Group type: COMPARATOR
Intervention: Isobaric bupivacaine 13.75 mg
Number of subjects: 0
Study: 2468931

Group type: EXPERIMENTAL
Intervention: Intranasal administration of synthetic human natriuretic peptide (4‐28 hANP) at doses of 50, 100, 200, and 500 micrograms.
Number of subjects: 6

Group type: COMPARATOR
Intervention: Vehicle administered randomly between doses of hANP.
Number of subjects: 6
Study: 14651

Group type: EXPERIMENTAL
Intervention: carpipramine
Number of subjects: 30

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 30
Study: 29343088

Group type: EXPERIMENTAL
Intervention: Promotion messages (e.g., 'Live your best life - Take your medications')
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Prevention messages (e.g., 'team up with your provider to create a combination of medications to prevent illness')
Number of subjects: 20
Study: 27397061

Group type: EXPERIMENTAL
Intervention: Combination therapy with fenofibrate (200 mg/day or 160 mg/day) and ezetimibe (10 mg/day)
Number of subjects: 236

Group type: COMPARATOR
Intervention: Fenofibrate monotherapy
Number of subjects: 236

Group type: COMPARATOR
Intervention: Ezetimibe monotherapy
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Combination therapy with fenofibrate and ezetimibe
Number of subjects: 236